Phytochemical investigation of the aerial parts of Cichorium intybus L. resulted in the isolation and identification of two new natural metabolites, 2,6-di[but-3(E)-en-2-onyl]naphthalene (1), and 3,3',4,4'-tetrahydroxychalcone (2), along with nine known compounds. Their structures were determined by spectroscopic techniques including 1D and 2D NMR. The known compounds were identified as scopoletin (3), 4-hydroxyphenylacetic acid (4), 3-hydroxy-4-methoxybenzoic acid (5), 4,4'-dihydroxychalcone (6), 6,7-dihydroxycoumarine (7), 1-triacontanol (8), lupeol (9), β-sitosterol (10), and β-sitosterol-3-O-β-glucopyranoside (11). Compounds 4-6 and 8 are reported for the first time from C. intybus. Compounds 2 and 3 showed weak inhibitory activities against urease and α-chymotrypsin enzymes, respectively.
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Cichorium intybus L. (Asteraceae), commonly known as 'wild endive', is a small to medium size perennial herb. It is also known as Kasini in Urdu (Pakistan) and Chicory in English [1, 2] . The root of C. intybus has carminative, diuretic, and hypoglycemic effects. It is also used in the treatment of jaundice, liver enlargement, gout, and rheumatism. The whole plant is used to cure fever, vomiting, diarrhea, and as an alexiferic [3] . Previous reports on C. intybus indicated the presence of anthocyanins [4] , sesquiterpene lactones [5, 6] , fructans [7] , flavonoids [8] , and coumarins [9, 10] . Based on its medicinal importance, C. intybus was investigated for new metabolites that may be useful as therapeutics.
Consequently, two new aromatic constituents, 2,6-di[but-3(E)-en-2-onyl]naphthalene (1) and 3,3',4,4'-tetrahydroxychalcone (2) (Figure 1 ), as well as nine known compounds were isolated from its aerial parts. Structure elucidation was performed using NMR spectroscopy and HR-EI-MS techniques. We further evaluated the isolated compounds for urease and α-chymotrypsin inhibitory potentials.
Compound 1 was obtained as colorless oil, with an intense band at 1728 cm -1 in its IR spectrum, indicating a conjugated ketone function. The molecular formula was determined as C 18 H 16 O 2 on the basis of HR-EI-MS, which displayed a pseudo-molecular ion [M-CH 3 ] + at m/z 249.0901 (calcd 249.0915) due to the loss of a terminalmethyl from the M + ion. The 1 H NMR spectrum of 1 showed a resonance at δ H 2.37 for three protons, characteristic of a methyl group attached to a carbonyl group. Two characteristic doublets were observed in the down-field region, at δ H 6.73 and 7.47, with 16.0 Hz coupling constants, corresponding to trans-oriented olefinic protons αand βto a carbonyl carbon, respectively. An ABX pattern at δ H 7.53 (dd, J 3,4 = 6.6, J 3 (Figure 2 ). The conjugated enone function between the two phenyl rings was supported by the HMBC interactions of H-2'' with C-1, C-1'' and H-3'' with C-1, C-2, C-6, and C-1''. Consequently, the structure of 2 was elucidated as 3,3',4,4'-tetrahydroxychalcone. To the best of our knowledge, compound 2 is a new natural product, previously reported as a synthetic analogue [11] .
The known compounds were identified as scopoletin (3) [9], 4-hydroxyphenylacetic acid (4) [12] , 3-hydroxy-4methoxybenzoic acid (5) [13] , 4,4'-dihydroxychalcone (6) [14] , 6,7-dihydroxycoumarine (7) [6, 9] , 1-triacontanol (8) [15] , lupeol (9) [6] , β-sitosterol (10) [6] , and β-sitosterol-3-O-β-glucopyranoside (11) [6] by comparing their spectral data with earlier reports. Compounds 4-6 and 8 were isolated for the first time from this plant.
The isolated compounds were evaluated for in vitro inhibition against urease and α-chymotrypsin enzymes. Compounds 2 and 3 exhibited weak urease (66.4% with 0.5 mM, IC 50 332.6 ± 3.3) and α-chymotrypsin (50.2% with 0.5 mM, IC 50 491.5 ± 4.8) inhibitory activity, compared with thiourea (98.2% with 0.5 mM, IC 50 21.0 ± 0.01) and chymostatin (98.6% with 0.125 mM, IC 50 5.7 ± 0.13). The rest showed less than 50% inhibition of the enzymes at a concentration of 0.5 mM.
Experimental

General experimental procedures:
Column chromatography (CC) and vacuum liquid chromatography (VLC) were performed on silica gel (70-230 mesh, E. Merck), and thick layer chromatography (TLC) on precoated silica gel GF 254 preparative plates (20 20, 0.5 mm, E. Merck). NMR spectra were recorded on Bruker AM-300, AM-400 and AMX-500 spectrometers. UV and IR spectra were obtained from Thermoelectron-Visionpro SoftwareV4.10 and Shimadzu FTIR-8900 spectrometers, respectively. EI-and HR-EI-MS were obtained on Finnigan MAT-112 and MAT-113 spectrometers. FAB MS were recorded on a Jeol JMS HX 110 spectrometer.
Plant material:
The aerial parts of Cichorium intybus L. were collected from Gilgit, Pakistan in July, 2007 and identified by the taxonomist at the Department of Botany, University of Karachi, where a voucher specimen (No. 1036, general herbarium # 71320) was deposited.
Extraction and isolation:
The powdered, shade dried aerial parts of Cichorium intybus (9.5 kg) were soaked in 95% ethanol (30 L) for 7 days. The resulting extract (418 g) was fractionated with hexanes, dichloromethane, ethyl acetate, n-butanol, and subsequently distilled water to yield hexanes (190 g), ethyl acetate (45 g), and n-butanol (132 g) soluble parts. The ethyl acetate soluble portion was subjected to VLC over silica gel using hexanes/ethyl acetate and ethyl acetate/methanol gradient systems in increasing order of polarity to obtain 14 fractions (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . with increasing proportions of ethyl acetate to obtain 3 fractions (3A, 49:1), (3B, 13:7), and (3C, 7:3). Fraction 3A was treated by preparative TLC (chloroform/methanol, 9:1) to purify 3-hydroxy-4-methoxybenzoic acid (10 mg). Scopoletin (12.7 mg) and 4-hydroxyphenylacetic acid (20.3 mg) from fraction 3B and 4,4'-dihydroxychalcone (15.6 mg) from fraction 3C were obtained by preparative TLC using chloroform/methanol (9.8:0.2) and chloroform/ methanol (9:1), respectively. Fraction 4 (1.6 g) was subjected to CC using hexanes/ethyl acetate mixtures to obtain 6 fractions (4A-4F). 2,6-Di[but-3(E)-en-2onyl]naphthalene (22.4 mg) was obtained in purified form from fraction 4A by elution with hexanes/ethyl acetate 9.6:0.4). Fraction 4E was eluted with hexanes/ethyl acetate (17:3) and purified by preparative TLC (chloroform/ methanol, 9:1) to yield 3,3',4,4'-tetrahydroxychalcone (13.8 mg) and 6, 7-dihydroxycoumarin (16.9 mg). 
2,6-Di[but-3(E)-en-2-onyl]naphthalene
Urease inhibition assay:
Urease enzyme (jack bean) solution (25 µL) and 5 μL of test compounds (0.5 mM) were incubated with 55 μL of buffers containing 100 mM urea for 15 min at 37°C in each well of a 96-well plate. Ammonia production was measured as urease activity by the indophenol method [16] . Final volumes were maintained at 200 µL by adding 45 µL phenol reagent (1% w/v phenol and 0.005%, w/v, sodium nitroprussside), and 70 μL of alkali reagent (0.5% w/v NaOH and 0.1% active chloride NaOCl) to each well. Using a microplate reader (Molecular Devices, CA, USA), the increase in absorbance was measured at 630 nm after 50 min at pH 6.8. The results (change in absorbance per min) were collected using softMax Pro software (Molecular Devices, CA, USA). Thiourea was used as the standard inhibitor and percentage inhibitions were calculated as follows: 100-(OD testwell /OD control ) ×100 [17] .
Chymotrypsin inhibition assay:
This was performed in 50 mM Tris-HCl buffer pH 7.6 with 10 mM CaCl 2 using the method of Cannell et al. [18] , with slight modification. α-Chymotrypsin (12 Units/mL prepared in buffer) with the test compound (0.5 mM prepared in DMSO) was incubated at 30°C for 25 min. The reaction was started by adding N-succinyl-L-phenylalanine-p-nitroanilide (SPpNA; 0.4 mM prepared in buffer). The change in absorbance was continuously monitored at 410 nm. The positive control without test compound and the negative control without enzyme or with standard inhibitor were run in parallel. The % inhibition was calculated as: 100-(OD testwell /OD control ) ×100.
